{
    "code": "01032886",
    "許可證字號": "衛署藥製字第032886號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "104\/08\/09",
    "發證日期": "79\/08\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103288607",
    "中文品名": "瑞汎樂巴順錠２．５公絲（布克丁）",
    "英文品名": "UPDOPA TABLETS 2.5MG (BROMOCRIPTINE) \"JINUP\"",
    "適應症": "經閉、乳漏、女性不孕症、抑制泌乳、產後乳房充盈、帕金森氏症、月經前乳房症候群、催乳激素過高所引起之男性性腺機能不足、精子過少肢端肥大症",
    "劑型": "110錠劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "BROMOCRIPTINE (MESILATE)",
    "限制項目": [
        "01國產",
        "09委託製造"
    ],
    "申請商名稱": "1304418200  瑞人企業股份有限公司",
    "申請商地址": "嘉義縣民雄鄉中庄路14-1號",
    "主製造廠": {
        "製造廠名稱": "1421417300  壽元化學工業股份有限公司湖內廠",
        "製造廠廠址": "嘉義市新民路１２８號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600009110",
            "成分名稱": "BROMOCRIPTINE (MESILATE)",
            "含量描述": "(2.87MG) 2.5",
            "含量": "",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "D-4",
        "標記二": "瑞人3"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=01032886&Seq=245&Type=10"
        }
    ]
}